High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients

Clinical trial NCT03179761 · COMPLETED

Trial details

NCT number: NCT03179761
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hematopoietic Cell Transplantation

Start date: 2017-10-09
Primary completion: 2022-02-15
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.